Advanced search
Publication Cover
Journal of Drug Targeting Volume 24, 2016 - Issue 1
Submit an article Journal homepage
356
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

Annette OrlethDepartment of Medical Oncology, University Hospital, Basel, Switzerland, ;Department of Biomedicine, University of Basel, Basel, Switzerland,
,
Christoph MamotDepartment of Biomedicine, University of Basel, Basel, Switzerland, ;Division of Medical Oncology, Cantonal Hospital, Aarau, Switzerland, and
,
Christoph RochlitzDepartment of Medical Oncology, University Hospital, Basel, Switzerland, ;Department of Biomedicine, University of Basel, Basel, Switzerland,
,
Reto RitschardDepartment of Medical Oncology, University Hospital, Basel, Switzerland, ;Department of Biomedicine, University of Basel, Basel, Switzerland,
,
Kari AlitaloBiomedicum Helsinki, Haartman Institute, University of Helsinki, Helsinki, Finland
,
Gerhard ChristoforiDepartment of Biomedicine, University of Basel, Basel, Switzerland,
&
Andreas WickiDepartment of Medical Oncology, University Hospital, Basel, Switzerland, ;Department of Biomedicine, University of Basel, Basel, Switzerland, Correspondence[email protected]
 show all
Pages 80-89 | Received 27 Mar 2015, Accepted 26 May 2015, Published online: 23 Jul 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mingting Wang, Qin Zeng, Yuan Li, Saber Imani, Danna Xie, Yinghua Li, Yunwei Han & Juan Fan. (2020) Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo. Journal of Drug Targeting 28:9, pages 961-969.
Read now

Articles from other publishers (13)

Nahid S Awad, Najla M Salkho, Waad H Abuwatfa, Vinod Paul, Nour M AlSawaftah & Ghaleb A Husseini. (2023) Tumor vasculature vs tumor cell targeting: Understanding the latest trends in using functional nanoparticles for cancer treatment. OpenNano 11, pages 100136.
Crossref
Uzma Azeem Awan, Muhammad Naeem, Rida Fatima Saeed, Sara Mumtaz & Nosheen Akhtar. 2023. Therapeutic Approaches in Cancer Treatment. Therapeutic Approaches in Cancer Treatment 207 235 .
Muneeb U. Rehman, Andleeb Khan, Zuha Imtiyaz, Shafat Ali, Hafiz Antar Makeen, Summya Rashid & Azher Arafah. (2022) Current nano-therapeutic approaches ameliorating inflammation in cancer progression. Seminars in Cancer Biology 86, pages 886-908.
Crossref
Vijay Gyanani, Jeffrey C. Haley & Roshan Goswami. (2021) Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems. Pharmaceuticals 14:9, pages 835.
Crossref
Yihan Yao, Yunxiang Zhou, Lihong Liu, Yanyan Xu, Qiang Chen, Yali Wang, Shijie Wu, Yongchuan Deng, Jianmin Zhang & Anwen Shao. (2020) Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Frontiers in Molecular Biosciences 7.
Crossref
Jiaxing Di, Fang Xie & Yuhong Xu. (2020) When liposomes met antibodies: Drug delivery and beyond. Advanced Drug Delivery Reviews 154-155, pages 151-162.
Crossref
Guangsheng Du & Xun Sun. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 527 548 .
Magdalena Bamburowicz-Klimkowska, Magdalena Poplawska & Ireneusz P. Grudzinski. (2019) Nanocomposites as biomolecules delivery agents in nanomedicine. Journal of Nanobiotechnology 17:1.
Crossref
Sakurai, Akita & Harashima. (2019) Targeting Tumor Endothelial Cells with Nanoparticles. International Journal of Molecular Sciences 20:23, pages 5819.
Crossref
Suresh Ambati, Aileen R. Ferarro, S. Earl Kang, Jianfeng Lin, Xiaorong Lin, Michelle Momany, Zachary A. Lewis & Richard B. Meagher. (2019) Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy. mSphere 4:1.
Crossref
Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally & Gehanne A.S. Awad. (2017) Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors. European Journal of Pharmaceutical Sciences 104, pages 273-292.
Crossref
Ernesta Fagiani, Pascal Lorentz, Ruben Bill, Kirusigan Pavotbawan, Lucie Kopfstein & Gerhard Christofori. (2016) VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue. Angiogenesis 19:3, pages 339-358.
Crossref
S.P. Egusquiaguirre, J.L. Pedraz, R.M. Hernández & M. Igartua. 2016. Nanoarchitectonics for Smart Delivery and Drug Targeting. Nanoarchitectonics for Smart Delivery and Drug Targeting 813 869 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.